The EuroMBR project (European microbioreactor) is part of an initial training network in which versatile microbioreactors are developed that are capable to be used in various processes and analyte screenings. The cooperation partners are both universities in seven European countries and microbiotechnology related companies in four European countries.
The SAMOSS project (Sample In – Answer Out Optochemical Sensing Systems) is part of an initial training network in which optochemical sensor systems are developed that are capable of performing a chain of operations starting from autonomous sample processing to reporting the result.
In this collaborative project novel microfluidic devices are developed to objectively assess and monitor food produce and food product quality. This is done by exposing and monitoring the response of cells expressing recombinant G-protein coupled receptors (GPCRs) developed at Plant Research International (Wageningen, The Netherlands).
The BRAVO project aims at developing a point-of-care diagnostic test for early detection of rheumatoid arthritis (RA). The test is based on an impedrimetric biosensor integrated in a microfluidic cartridge. The sensor allows multiplex measurement of disease markers to be carried out using a single drop of patients’ blood as a input, thereby offering a great improvement to the diagnosis and treatment of RA.
The goal of the NirionPlus project is to develop a point-of-care device that enables kidney patients to measure sodium, potassium and creatinine levels in their own blood and urine samples in a fast and effective way.
The TissueGEN project focuses on the production of an in vitro human disease tissue platform technology to enable and accelerate the development of regenerative medicine therapies for a diverse range of diseases.
Together with a crack team of specialists in diverse fields, Micronit is developing an electronic nose to detect volatile biomarkers of early stage lung cancer in the breath of patients. Within the LCAOS project (Lung Cancer Artificial Olfactory System) novel diagnostic tools are developed to detect: (I) the presence of lung cancer, and (II) to assess the risk of a patient developing lung cancer in the future.
The Project ‘Innovation to IndustrialisatSequential flow deviceion for advanced Micro- and Nanosystems’ (I2I) started in spring 2012. This project was initiated by Business Cluster Semiconductors to supports SME companies active in micro-and nanotechnology to further industrialize their developed technologies and applications.
In the µBLM project, a complete set-up for multiplexed measurements on membrane proteins utilizing black lipid membranes (BLMs) will be developed